Arkansas Administrative Code › Agency 070 - Board of Pharmacy › Rule 070.00.97-007 - Regulation 63 - Drug Therapy Management by a Pharmacist Under Written Protocol of a Physician

Current through Register Vol. 49, No. 6, June, 2024
REGULATION
		  63
DRUG THERAPY MANAGEMENT BY A PHARMACIST UNDER WRITTEN PROTOCOL OF
			 A PHYSICIAN
The purpose of this regulation is to provide standards for the
			 maintenance of records of a pharmacist engaged in the provision of drug therapy
			 management as authorized in §
								17-92-101(14)
			 and §
								17-92-205(a).
(A) DEFINITIONS: The following words and
		  terms, when used in this regulation, shall have the following meanings, unless
		  the context clearly indicates otherwise:
(1)
		  ACT - The Arkansas Pharmacy Practice Act
(2) BOARD - The Arkansas State Board of
		  Pharmacy
(3) CONFIDENTIAL RECORD -
		  any health-related record maintained by a pharmacy or pharmacist-such as a
		  patient medication record, prescription drug order, or medication
		  order.
(4) DRUG THERAPY MANAGEMENT
		  -The performance of specific acts of drug therapy management delegated to a
		  pharmacist for an individual patient by an authorized practitioner through
		  written protocol. (Drug therapy management shall not include the selection of
		  drug products not prescribed by the practitioner, unless the drug product is
		  named in the practitioner initiated protocol.)
(5) WRITTEN PROTOCOL - A practitioner's
		  order, standing medical order, standing delegation order, or other order or
		  protocol as defined by rule of the Arkansas State Medical Board under the
		  Medical Practice Act.
(a) A written protocol
		  must contain at a minimum the following:
(i) a
		  statement identifying the individual practitioner authorized to prescribe drugs
		  and responsible for the delegation of drug therapy management;
(ii) a statement identifying the individual
		  pharmacist authorized to dispense drugs and to engage in drug therapy
		  management delegated by the practitioner;
(iii) a statement identifying the types of
		  drug therapy management decisions that the pharmacist is authorized to make
		  which shall include:
(I) A statement of the
		  ailments or diseases involved, drugs, and types of drug therapy management
		  authorized; and
(II) A specific
		  statement of the procedures, decision criteria, or plan the pharmacist shall
		  follow when exercising drug therapy management authority;
(iv) A statement of the activities the
		  pharmacist shall follow in the course of exercising drug therapy management
		  authority, including the method for documenting decisions made and a plan for
		  communication or feedback to the authorizing physician concerning specific
		  decisions made Documentation shall be recorded within a reasonable time of each
		  intervention and may be performed on the patient medication record patient
		  medical chart, or in a separate log book; and
(v) A statement that describes appropriate
		  mechanisms and time schedule for the pharmacist to report to the physician
		  monitoring the pharmacist's exercise of delegated drug therapy management and
		  the resuits of the drug therapy management.